• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性原发性肺癌的外科治疗

Surgical treatment of multiple primary lung cancers.

作者信息

Verhagen A F, van de Wal H J, Cox A L, Lacquet L K

机构信息

Department of Thoracic and Cardiac Surgery, University Hospital Sint-Radboud, Nijmegen, Netherlands.

出版信息

Thorac Cardiovasc Surg. 1989 Apr;37(2):107-11. doi: 10.1055/s-2007-1013919.

DOI:10.1055/s-2007-1013919
PMID:2543100
Abstract

Multiple primary lung cancers are now being recognized more frequently. Out of 1004 patients with a resected lung cancer, 32 (3.2%) presented a second primary and two of them a third primary lung cancer. A synchronous (S) primary was present in 7 and a metachronous (M) primary was present in 25. The histology was different in 1/7 with a S. and in 6/25 with a M. cancer. In all cases the cancer was located in another segment, lobe or lung. Out of the 7 with a S. cancer, 3 had a one stage and 4 a staged resection; out of the 25 with a M. cancer, 3 were treated by chemotherapy, 22 had a 2nd and 1 a 3rd operation to remove a new cancer. The mean time interval in M. cancer was 4 years, 8 months and was longer for adeno- (8 years) than for squamous cell carcinomas (4 years), longer for a contralateral cancer (6 years, 7 months) and longer for mild smokers (5 years, 1 month). The early mortality (10.3%) was 0/7 for S. and 3/22 for M. cancers. The three and five years actuarial survival of operated patients was 67% and 25% for S. and 43% and 31% for M. cancers. Survival is positively affected by a resection interval of more than 3 years and by 3 instead of 2 remaining lobes after the second resection. In conclusion a close follow-up of operated lung cancer patients is necessary and aggressive surgical approach is indicated for a new primary cancer.

摘要

现在,多原发性肺癌的确诊更为常见。在1004例接受肺癌切除术的患者中,32例(3.2%)出现了第二原发性肺癌,其中2例出现了第三原发性肺癌。7例为同时性(S)原发性肺癌,25例为异时性(M)原发性肺癌。7例S期肺癌中有1例组织学不同,25例M期肺癌中有6例组织学不同。所有病例中,癌症均位于另一个肺段、肺叶或另一侧肺。7例S期癌症患者中,3例接受了一期切除,4例接受了分期切除;25例M期癌症患者中,3例接受了化疗,22例接受了第二次手术,1例接受了第三次手术以切除新的癌症。M期癌症的平均时间间隔为4年8个月,腺癌(8年)比鳞状细胞癌(4年)更长,对侧癌症(6年7个月)更长,轻度吸烟者(5年1个月)更长。早期死亡率S期为0/7,M期为3/22。手术患者的三年和五年精算生存率S期分别为67%和25%,M期分别为43%和31%。切除间隔超过3年以及第二次切除后保留3个而非2个肺叶对生存率有积极影响。总之,对接受手术的肺癌患者进行密切随访是必要的,对于新的原发性癌症应采取积极的手术方法。

相似文献

1
Surgical treatment of multiple primary lung cancers.多发性原发性肺癌的外科治疗
Thorac Cardiovasc Surg. 1989 Apr;37(2):107-11. doi: 10.1055/s-2007-1013919.
2
Multiple primary lung cancers.多发性原发性肺癌
Thorac Cardiovasc Surg. 1994 Feb;42(1):40-4. doi: 10.1055/s-2007-1016453.
3
Surgical treatment of primary lung cancer with synchronous brain metastases.原发性肺癌伴同步脑转移的外科治疗
J Thorac Cardiovasc Surg. 2001 Sep;122(3):548-53. doi: 10.1067/mtc.2001.116201.
4
[Multiple primary cancers of the bronchi].[支气管多原发性癌]
Ann Chir. 1993;47(8):721-8.
5
[Surgical treatment of the second primary lung cancer].[第二原发性肺癌的外科治疗]
Zhonghua Zhong Liu Za Zhi. 1988 Jan;10(1):42-4.
6
Survival following resection for second and third primary lung cancers.第二次和第三次原发性肺癌切除术后的生存率。
J Thorac Cardiovasc Surg. 1984 Oct;88(4):502-10.
7
[Surgery for multiple primary lung cancers].[多原发性肺癌的外科治疗]
Kyobu Geka. 2002 Jan;55(1):10-4.
8
[Surgical treatment for bilateral multiple lung cancers].[双侧多发性肺癌的外科治疗]
Kyobu Geka. 2000 Feb;53(2):89-94; discussion 94-6.
9
[Reoperation for recurrent or second primary lung cancer].[复发性或第二原发性肺癌的再次手术]
Kyobu Geka. 1995 Jan;48(1):24-8.
10
[Diagnosis and surgical treatment of double primary lung cancer].[双原发性肺癌的诊断与外科治疗]
Zhonghua Zhong Liu Za Zhi. 2001 Sep;23(5):428-30.

引用本文的文献

1
Correlation between gene mutation status and clinicopathologic features in early multiple primary lung cancer.早期多原发性肺癌基因突变状态与临床病理特征的相关性
Front Oncol. 2023 Apr 12;13:1110259. doi: 10.3389/fonc.2023.1110259. eCollection 2023.
2
Prior Treatment for Non-small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy: A Retrospective Multivariate and Matched Pair Analysis.先前针对非小细胞肺癌的治疗与接受立体定向体部放射治疗后续肺部恶性肿瘤的患者的生存改善相关:一项回顾性多变量和配对分析。
Am J Clin Oncol. 2021 Jan 1;44(1):18-23. doi: 10.1097/COC.0000000000000778.
3
Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report.
2例同步性肺腺癌和肺鳞癌患者的基因组图谱和转录组微环境:病例报告
BMC Med Genomics. 2020 Jan 31;13(1):15. doi: 10.1186/s12920-020-0663-8.
4
A Rare Case Of Synchronous Multiple Primary Lung Cancer: Squamous Cell Cancer And Small Cell Lung Cancer.同步性多原发性肺癌的罕见病例:鳞状细胞癌和小细胞肺癌
Onco Targets Ther. 2019 Oct 24;12:8801-8806. doi: 10.2147/OTT.S213259. eCollection 2019.
5
"Different trend" in multiple primary lung cancer and intrapulmonary metastasis.多原发性肺癌与肺内转移的“不同趋势”
Eur J Med Res. 2015 Feb 20;20(1):17. doi: 10.1186/s40001-015-0109-5.
6
"Unique trend" and "contradictory trend" in discrimination of primary synchronous lung cancer and metastatic lung cancer.原发性同步性肺癌与转移性肺癌鉴别诊断中的“独特趋势”与“矛盾趋势”
BMC Cancer. 2013 Oct 9;13:467. doi: 10.1186/1471-2407-13-467.
7
Suggestive synchronous triple squamous cell carcinoma of the lung in the same lobe.提示同一肺叶内同步性三原发性肺鳞状细胞癌。
Gen Thorac Cardiovasc Surg. 2010 Aug;58(8):427-30. doi: 10.1007/s11748-009-0476-3. Epub 2010 Aug 12.
8
Synchronous growth of triple lung cancer.
Surg Today. 1995;25(12):1054-6. doi: 10.1007/BF00311693.
9
[The effectiveness of standardized follow-up studies after resection of non-small cell bronchial carcinoma].[非小细胞支气管癌切除术后标准化随访研究的有效性]
Langenbecks Arch Chir. 1994;379(5):299-306. doi: 10.1007/BF00186397.